Kent Rogers

With decades of leadership experience across pharma, biotech, PBMs, and venture-backed innovation, Kent Rogers brings a unique lens to the future of drug commercialization. As CEO of EveryONE Medicines and former CCO of EQRx and SVP at Optum, Kent has shaped bold new models around access, pricing, and payer-provider alignment. In this provocative opening keynote, he’ll explore why pharma’s current structure is no longer sustainable—and what will emerge in its place.

• Understand the US pressure to remove reliance on global suppliers – is that realistic?
• Navigate the next branded drug frontier as the Specialty patent cliff continues 
• Anticipate the expansion of government price negotiations—are we moving toward a single-payer system?
• Redefine how we think about the new pharma model in this context

As the global pharmaceutical supply chain becomes increasingly complex, the pressure to remain resilient and cost-efficient is mounting. From rising geopolitical tensions and shifting trade alliances to escalating tariffs and inflationary costs, pharma leaders are being forced to re-evaluate sourcing strategies, regionalization plans, and risk mitigation frameworks.

In this dynamic closing panel, senior supply chain and policy leaders will discuss:

·        Learn how global instability is shaping pharma’s operational decisions and long-term strategy

·        Discuss what new and proposed tariffs mean for the future of pharmaceutical manufacturing, sourcing, and pricing

·        Discover how companies are rethinking supplier diversification, nearshoring, and inventory strategies to stay ahead of uncertainty